152 related articles for article (PubMed ID: 9198581)
1. Measurement of the radioactive body burden in patients receiving iodine-131 treatment for carcinoma of the thyroid.
Ravichandran R; Supe SS; Jayasree U; Devaru S
Eur J Nucl Med; 1997 Apr; 24(4):464. PubMed ID: 9198581
[No Abstract] [Full Text] [Related]
2. Blood and bone marrow dosimetry in radioiodine therapy of thyroid cancer.
Sgouros G
J Nucl Med; 2005 May; 46(5):899-900; author reply 901. PubMed ID: 15872367
[No Abstract] [Full Text] [Related]
3. Blood and bone marrow dosimetry in radioiodine therapy of differentiated thyroid cancer after stimulation with rhTSH.
Lassmann M; Hänscheid H; Reiners C; Thomas SR
J Nucl Med; 2005 May; 46(5):900-1; author reply 901. PubMed ID: 15872369
[No Abstract] [Full Text] [Related]
4. A comparison of physical and cytogenetic estimates of radiation dose in patients treated with iodine-131 for thyroid carcinoma.
Llloyd DC; Purrott RJ; Dolphin GW; Horton PW; Halnan KE; Scott JS; Mair G
Int J Radiat Biol Relat Stud Phys Chem Med; 1976 Nov; 30(5):473-85. PubMed ID: 1087288
[TBL] [Abstract][Full Text] [Related]
5. Radiation exposure to the family of radioactive patients.
Harbert JC; Wells N
J Nucl Med; 1974 Oct; 15(10):887-8. PubMed ID: 4418007
[No Abstract] [Full Text] [Related]
6. Radioiodine as an adjuvant therapy and its role in follow-up of differentiated thyroid cancer.
Padma S; Sundaram PS
J Cancer Res Ther; 2016; 12(3):1109-1113. PubMed ID: 28054519
[TBL] [Abstract][Full Text] [Related]
7. Autopsy experience with a radioactive cadaver.
Johnston AS; Minarcik J; Rossi R; Pinsky S
Health Phys; 1979 Aug; 37(2):231-6. PubMed ID: 536202
[No Abstract] [Full Text] [Related]
8. Treatment of medullary carcinoma of the thyroid with I-131.
Nusynowitz ML; Pollard E; Benedetto AR; Lecklitner ML; Ware RW
J Nucl Med; 1982 Feb; 23(2):143-6. PubMed ID: 7057256
[TBL] [Abstract][Full Text] [Related]
9. [Possible sequelae of the action of radioactive iodine in man].
Il'in LA; Arkhangel'skaia GV
Med Radiol (Mosk); 1973 Aug; 18(8):66-80. PubMed ID: 4801844
[No Abstract] [Full Text] [Related]
10. NRC absorbed dose reconstruction for family member of 131I therapy patient: case study and commentary.
Marcus CS; Siegel JA
J Nucl Med; 2004 Apr; 45(4):13N-6N, 37N. PubMed ID: 15073236
[No Abstract] [Full Text] [Related]
11. Restrictions following iodine-131 treatment--a time for change or more data required?
Mountford PJ; O'Doherty MJ
Eur J Nucl Med; 1994 Sep; 21(9):903-5. PubMed ID: 7995282
[No Abstract] [Full Text] [Related]
12. Bone marrow dosimetry and safety of high 131I activities given after recombinant human thyroid-stimulating hormone to treat metastatic differentiated thyroid cancer.
de Keizer B; Hoekstra A; Konijnenberg MW; de Vos F; Lambert B; van Rijk PP; Lips CJ; de Klerk JM
J Nucl Med; 2004 Sep; 45(9):1549-54. PubMed ID: 15347723
[TBL] [Abstract][Full Text] [Related]
13. Role of radioiodine in management of thyroid cancer: experience with 70 cases.
Afroz S; Ahmed K; Yasmeen S; Ahmed F; Nisa L
Bangladesh Med Res Counc Bull; 1992 Dec; 18(2):68-71. PubMed ID: 1303083
[TBL] [Abstract][Full Text] [Related]
14. Online regulatory guide errors.
Dawry FP
J Nucl Med; 2002 Feb; 43(2):284. PubMed ID: 11858234
[No Abstract] [Full Text] [Related]
15. Low-dose and high-dose radioiodine in thyroid cancer.
Ryo UY
Am J Med; 1977 Jul; 63(1):167-8. PubMed ID: 879192
[No Abstract] [Full Text] [Related]
16. EVALUATION OF THE RELEASE CRITERIA FROM HOSPITAL OF THYROID CARCINOMA PATIENT TREATED WITH 131I.
Lahfi Y; Anjak O
Radiat Prot Dosimetry; 2016 Dec; 171(4):534-538. PubMed ID: 26590393
[TBL] [Abstract][Full Text] [Related]
17. Uptake of ¹³¹I in households of thyroid cancer patients.
North DL
Health Phys; 2013 Apr; 104(4):434-6. PubMed ID: 23439148
[TBL] [Abstract][Full Text] [Related]
18. Radiation protection recommendations for I-131 thyrotoxicosis, thyroid cancer and phaeochromocytoma patients.
Woodings S
Australas Phys Eng Sci Med; 2004 Sep; 27(3):118-28. PubMed ID: 15580841
[TBL] [Abstract][Full Text] [Related]
19. Correlation between external exposure and activity in patients undergoing 131I thyroid cancer therapy.
Barquero R; Basurto F; Vega-Carrillo HR; Iñiguez MP; Ferrer N; Esteban R
Health Phys; 2008 Aug; 95(2):227-33. PubMed ID: 18617804
[TBL] [Abstract][Full Text] [Related]
20. Radiation safety precautions with 131iodine therapy.
Greenfield LD; Herman MW; Patrick J
Cancer Nurs; 1978 Oct; 1(5):379-84. PubMed ID: 250446
[No Abstract] [Full Text] [Related]
[Next] [New Search]
